Neuland Labs
₹20,360
- Market Cap
- ₹25,284Cr.
- P/E Ratio
- 50.8
- P/B Ratio
- 13.94
- EPS (TTM)
- ₹400.79
- Div Yield
- 0.17%
- ROCE
- 26.5%
- ROE
- 21.2%
52W Low: ₹11,50052W High: ₹24,225
Themes:💊 Pharma & CDMO
Appears in 2 screens
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 19.0% a year over three years.
- Debt is 0.16× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Neuland_Labs — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 50.8P/E: 50.8 | P/B: 13.94Growth
GrowingSales CAGR — 3Y: 19% · 1Y: 78%Profitability
High MarginROCE: 26.5% | ROE: 21.2%Key Metrics
Valuation
PEG Ratio 1.69
Price / Sales 10.66x
Book Value ₹1461
Margins & returns
Operating Margin 32%
Net Margin 21.0%
Return on Assets 17.0%